Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Antti Luiro

Head of Nordic ER Development, Analyst

Antti Luiro portrait

Coverage

LeadDeskNightingale HealthLoihdeSpringvestAiforia TechnologiesQt Group

Latest content

ShowingAll content types

New study on benefits of Nightingale blood test in identifying cardiovascular disease risk

Analyst Comment 2025-12-18 09:14 by Antti Luiro, Antti Siltanen
Nightingale Health

Aiforia launches new AI platform

Analyst Comment 2025-12-18 08:25 by Antti Luiro, Frans-Mikael Rostedt
Aiforia Technologies

Changes in Nightingale’s management team continue

Analyst Comment 2025-12-15 08:59 by Antti Luiro, Antti Siltanen
Nightingale Health

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Springvest meddelade strategiskt samarbete

Analyst Comment 2025-12-11 08:15 by Kasper Mellas, Antti Luiro
Springvest

Aiforia raised 4.2 MEUR in a directed share issue

Analyst Comment 2025-12-11 08:35 by Antti Luiro, Frans-Mikael Rostedt
Aiforia Technologies

Springvests styrelse beslutade om ytterligare en utdelning för år 2025

Analyst Comment 2025-12-09 08:07 by Kasper Mellas, Antti Luiro
Springvest

Nightingale's CFO departs suddenly

Analyst Comment 2025-12-09 06:53 by Antti Luiro, Antti Siltanen
Nightingale Health

Nightingale expands its strategic partnership with Terveystalo

Analyst Comment 2025-11-27 10:12 by Antti Luiro
Nightingale Health

Springvest delar ut sina Solar Foods-aktier till sina ägare

Analyst Comment 2025-11-26 07:45 by Kasper Mellas, Antti Luiro
Springvest

Faron to draw additional 10 MEUR tranche from its convertible bond

Analyst Comment 2025-11-25 10:33 by Antti Luiro
Faron Pharmaceuticals
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.